![]() |
市場調查報告書
商品編碼
2108055
拋棄式組件市場進行分析和預測(至2035年):按類型、產品、服務、技術、組件、應用、材料類型、過程、最終用戶和功能Single-use Assemblies Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Component, Application, Material Type, Process, End User, Functionality |
||||||
全球拋棄式組件市場預計將從2025年的69億美元成長到2035年的288億美元,CAGR為15.3%。生物製藥生產的快速發展和先進生物製程技術的進步是推動拋棄式組件市場成長的主要因素。根據美國食品藥物管理局(FDA)統計,2025年有46種新藥獲得核准,其中12種為生物製藥(佔所有核准藥物的26%)。這凸顯了生物製藥生產行業的持續成長,拋棄式組件在該行業廣泛用於無菌流體轉移、過濾和污染控制。拋棄式生物製程系統的日益普及也進一步推動了市場成長。
拋棄式組件市場的「類型」細分包括標準組件、客製化組件和其他組件。其中,客製化組件佔據了較大的市場佔有率,這主要得益於生物製藥生產和先進療法生產中對靈活、應用特定的解決方案日益成長的需求。客製化拋棄式組件能夠根據特定的製程要求整合組件,幫助製造商最佳化工作流程、降低污染風險並提高營運效率。標準組件也因其成本效益高、易於取得以及適用於培養基製備、流體轉移和過濾等常規生物製程應用而廣泛採用。生物製藥、疫苗以及細胞和基因療法生產中拋棄式技術的日益普及,推動對標準和客製化組件解決方案的需求。
| 市場區隔 | |
|---|---|
| 類型 | 標準組件、客製組件、其他 |
| 產品 | 管材、連接器、過濾器、袋子、生物製程容器、接頭、夾具、閥門、歧管、其他 |
| 服務 | 安裝、驗證、維護、諮詢、訓練、其他 |
| 技術 | 3D列印、射出成型、吹塑成型、擠出成型、其他 |
| 組件 | 軟管接頭、魯爾接頭、Tri-Clamp、快速接頭、其他 |
| 用途 | 生物加工、製藥生產、疫苗生產、細胞療法、基因療法、其他 |
| 材料類型 | 聚乙烯、聚丙烯、矽酮、聚氯乙烯、熱可塑性橡膠、其他 |
| 過程 | 上游製程、下游製程、灌裝及包裝製程、其他 |
| 最終用戶 | 生物製藥公司、契約製造組織、研究機構、其他 |
| 功能 | 無菌、非無菌、其他 |
拋棄式組件市場的「材料類型」細分市場包括聚乙烯、聚丙烯、矽膠、聚氯乙烯和熱可塑性橡膠。其中,矽膠和聚丙烯因其優異的生物相容性、耐化學性、柔軟性以及適用於重要的生物製程應用而廣泛使用。聚乙烯因其耐用性和低萃取性,在流體處理和儲存應用領域日益受到關注。熱可塑性橡膠因其柔軟性和在拋棄式系統中更優異的性能,正擴大被用作傳統材料的替代品。對污染控制、法規遵循和高效生產流程的日益關注,進一步推動了拋棄式組件中尖端材料的應用。
到2025年,北美佔據全球拋棄式組件市場最大的佔有率,這主要得益於其先進的生物製藥製造產業、拋棄式技術的廣泛應用以及對生物製藥、疫苗、細胞和基因療法生產的大力投資。該地區匯聚了眾多領先的生物製藥公司、合約研發生產機構(CDMO)和受託研究機構(CRO),這些機構正擴大利用預組裝的拋棄式流體管理系統來提高生產柔軟性、降低污染風險並縮短生產週期。對單株抗體、生物相似藥和個人化醫療日益成長的需求,以及嚴格的無菌生產監管標準,進一步推動了市場成長。此外,生物製程技術和自動化領域的持續創新也鞏固了北美在全球拋棄式組件市場的主導地位。
亞太地區預計將成為拋棄式組件市場成長最快的地區,這主要得益於生物製藥生產的快速擴張、生技藥品產量的增加以及生物技術基礎設施投資的成長。中國、印度、韓國、日本和新加坡等國家正透過政府主導的措施、私人投資以及新建生技藥品生產設施來提升其生物製造能力。合約研發生產機構(CDMO)和生物技術公司擴大採用拋棄式生物製程系統,加之疫苗、生物相似藥和細胞療法的需求不斷成長,加速市場成長。此外,較低的製造成本、有利的監管趨勢以及全球生物製藥公司不斷增加的技術轉移預計將使亞太地區在整個預測期內成為成長最快的區域市場。
客製化和自動化拋棄式生物程序解決方案的應用日益廣泛:
在拋棄式組件市場,生物製藥生產領域正呈現出強勁的趨勢,即採用客製化、預先組裝的自動化拋棄式解決方案。製藥和生物技術公司正擴大用拋棄式組件(例如管路組件、袋裝組件、連接器和過濾單元)取代傳統的不銹鋼系統,以提高柔軟性、降低污染風險並縮短生產週期。材料科學、模組化設計和整合生物製程平台的進步,使製造商能夠為生物製藥、疫苗以及細胞和基因療法開發特定應用的解決方案。對可擴展且經濟高效的生產流程日益成長的關注,進一步推動了先進拋棄式技術的應用。
擴大生物製藥和細胞/基因療法的生產規模:
生物製藥、疫苗以及細胞和基因療法的產量不斷成長,是推動拋棄式組件市場發展的主要動力。先進療法的日益複雜化,需要柔軟性且污染可控的生產環境,推動了對拋棄式生物製程組件的需求。與傳統系統相比,拋棄式組件可減少製造商的清潔工作量,最大限度地降低交叉污染的風險,並縮短設備運作。此外,對生物製藥生產能力的投資增加、合約研發生產機構(CDMO)的擴張以及連續生物製程技術的日益普及,都為市場成長提供了支持。隨著對快速生產擴充性和高效生產流程的需求不斷成長,對拋棄式組件解決方案的需求也將持續加速成長。
The global Single-use Assemblies Market is projected to grow from $6.9 billion in 2025 to $28.8 billion by 2035, at a compound annual growth rate (CAGR) of 15.3%. The single-use assemblies market is driven by the rapid expansion of biologics manufacturing and advanced bioprocessing technologies. According to the U.S. FDA, 46 novel drugs were approved in 2025, including 12 biologics (26% of all approvals), highlighting continued growth in biologic drug manufacturing, where single-use assemblies are widely used for sterile fluid transfer, filtration, and contamination control. Increasing adoption of disposable bioprocessing systems is further supporting market growth.
The Type segment of the Single-use Assemblies Market includes standard assemblies, customized assemblies, and others. Among these, customized assemblies hold a significant market share due to the increasing demand for flexible, application-specific solutions in biopharmaceutical manufacturing and advanced therapeutic production. Customized single-use assemblies help manufacturers optimize workflows, reduce contamination risks, and improve operational efficiency by integrating components according to specific process requirements. Standard assemblies are also widely adopted due to their cost-effectiveness, easy availability, and suitability for routine bioprocessing applications such as media preparation, fluid transfer, and filtration. The growing adoption of single-use technologies in biologics, vaccines, and cell and gene therapy manufacturing is driving demand for both standard and customized assembly solutions.
| Market Segmentation | |
|---|---|
| Type | Standard Assemblies, Customized Assemblies, Others |
| Product | Tubing, Connectors, Filters, Bags, Bioprocess Containers, Fittings, Clamps, Valves, Manifolds, Others |
| Services | Installation, Validation, Maintenance, Consulting, Training, Others |
| Technology | 3D Printing, Injection Molding, Blow Molding, Extrusion, Others |
| Component | Hose Barb, Luer Lock, Tri-Clamp, Quick Connect, Others |
| Application | Bioprocessing, Pharmaceutical Manufacturing, Vaccine Production, Cell Therapy, Gene Therapy, Others |
| Material Type | Polyethylene, Polypropylene, Silicone, Polyvinyl Chloride, Thermoplastic Elastomer, Others |
| Process | Upstream Processing, Downstream Processing, Fill-Finish Applications, Others |
| End User | Biopharmaceutical Companies, Contract Manufacturing Organizations, Research Institutes, Others |
| Functionality | Sterile, Non-Sterile, Others |
The Material Type segment of the Single-use Assemblies Market includes polyethylene, polypropylene, silicone, polyvinyl chloride, thermoplastic elastomer, and others. Among these, silicone and polypropylene are widely used due to their excellent biocompatibility, chemical resistance, flexibility, and suitability for critical bioprocessing applications. Polyethylene is gaining traction for fluid handling and storage applications due to its durability and low extractable characteristics. Thermoplastic elastomers are increasingly adopted as alternatives to traditional materials because of their flexibility and improved performance in single-use systems. The rising focus on contamination control, regulatory compliance, and efficient manufacturing processes is further supporting the adoption of advanced materials in single-use assemblies.
North America held the largest share of the global single-use assemblies market in 2025, driven by its advanced biopharmaceutical manufacturing industry, widespread adoption of single-use technologies, and strong investments in biologics, vaccines, and cell and gene therapy production. The region is home to leading biopharmaceutical companies, contract development and manufacturing organizations (CDMOs), and contract research organizations (CROs) that increasingly utilize pre-assembled, disposable fluid management systems to improve manufacturing flexibility, reduce contamination risks, and shorten production timelines. Growing demand for monoclonal antibodies, biosimilars, and personalized medicines, coupled with stringent regulatory standards for sterile manufacturing, has further strengthened market growth. Additionally, continuous innovation in bioprocessing technologies and automation reinforces North America's leadership in the global single-use assemblies market.
Asia Pacific is expected to witness the highest growth in the single-use assemblies market owing to rapid expansion of biopharmaceutical manufacturing, increasing biologics production, and rising investments in biotechnology infrastructure. Countries such as China, India, South Korea, Japan, and Singapore are expanding their biomanufacturing capabilities through government initiatives, private investments, and the establishment of new biologics production facilities. Growing adoption of single-use bioprocessing systems by CDMOs and biotechnology companies, combined with increasing demand for vaccines, biosimilars, and cell therapies, is accelerating market growth. Furthermore, lower manufacturing costs, favorable regulatory developments, and increasing technology transfer from global biopharmaceutical companies are expected to position Asia Pacific as the fastest-growing regional market throughout the forecast period.
Increasing Adoption of Customized and Automated Single-Use Bioprocessing Solutions:
The Single-use Assemblies Market is witnessing a strong trend toward the adoption of customized, pre-assembled, and automated single-use solutions in biopharmaceutical manufacturing. Pharmaceutical and biotechnology companies are increasingly replacing traditional stainless-steel systems with disposable assemblies such as tubing sets, bags, connectors, and filtration units to improve flexibility, reduce contamination risks, and accelerate production timelines. Advances in material science, modular designs, and integrated bioprocessing platforms are enabling manufacturers to develop application-specific solutions for biologics, vaccines, and cell and gene therapies. The growing focus on scalable and cost-efficient manufacturing processes is further driving the adoption of advanced single-use technologies.
Expansion of Biologics and Cell & Gene Therapy Manufacturing:
The increasing production of biologics, vaccines, and cell and gene therapies is a major driver of the Single-use Assemblies Market. The growing complexity of advanced therapies requires flexible and contamination-controlled manufacturing environments, increasing demand for disposable bioprocessing components. Single-use assemblies help manufacturers reduce cleaning requirements, minimize cross-contamination risks, and enable faster facility turnaround compared with conventional systems. Additionally, rising investments in biopharmaceutical manufacturing capacity, expansion of contract development and manufacturing organizations (CDMOs), and increasing adoption of continuous bioprocessing technologies are supporting market growth. The need for rapid production scalability and efficient manufacturing workflows continues to accelerate demand for single-use assembly solutions.
Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.